Nicholas Marston

3.8k total citations · 2 hit papers
49 papers, 1.2k citations indexed

About

Nicholas Marston is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Nicholas Marston has authored 49 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Cardiology and Cardiovascular Medicine, 25 papers in Surgery and 13 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Nicholas Marston's work include Lipoproteins and Cardiovascular Health (20 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (11 papers) and Lipid metabolism and disorders (7 papers). Nicholas Marston is often cited by papers focused on Lipoproteins and Cardiovascular Health (20 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (11 papers) and Lipid metabolism and disorders (7 papers). Nicholas Marston collaborates with scholars based in United States, United Kingdom and Brazil. Nicholas Marston's co-authors include Marc S. Sabatine, Robert P. Giugliano, Anthony Keech, Michelle L. O’Donoghue, Stephen D. Wiviott, Peter Sever, Eugene Braunwald, Michael G. Silverman, Brian A. Ference and Bariş Gencer and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Circulation.

In The Last Decade

Nicholas Marston

41 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Olezarsen for Hypertriglyceridemia in Patients at High Cardiovascular Risk

2024 102 citations Brian A. Bergmark, Nicholas Marston et al. profile →
Lipoprotein(a), C-Reactive Protein, and Cardiovascular Risk in Primary and Secondary Prevention Populations

2024 44 citations Giorgio Melloni, Benjamin M. Scirica et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nicholas Marston United States	16	569	542	303	138	124	49	1.2k
Michael J. Blaha United States	18	521 0.9×	210 0.4×	349 1.2×	93 0.7×	82 0.7×	44	881
Alexander Vonbank Austria	20	393 0.7×	358 0.7×	276 0.9×	75 0.5×	229 1.8×	103	1.2k
Jong-Soon Park United States	12	793 1.4×	375 0.7×	632 2.1×	171 1.2×	101 0.8×	27	1.7k
Farhad Zangeneh United States	10	491 0.9×	250 0.5×	452 1.5×	122 0.9×	86 0.7×	17	994
Jordan Fulcher Australia	10	1.0k 1.8×	648 1.2×	421 1.4×	379 2.7×	229 1.8×	18	1.7k
Nick S. Nurmohamed Netherlands	19	534 0.9×	377 0.7×	185 0.6×	45 0.3×	133 1.1×	68	1.1k
Jacqueline Suk Danik United States	18	472 0.8×	395 0.7×	189 0.6×	46 0.3×	381 3.1×	26	1.4k
Wensheng Sun United States	16	655 1.2×	790 1.5×	421 1.4×	50 0.4×	160 1.3×	27	1.4k
Melchior C. Nierman Netherlands	15	357 0.6×	542 1.0×	325 1.1×	67 0.5×	133 1.1×	32	1.1k
Xavier García–Moll Spain	21	339 0.6×	647 1.2×	171 0.6×	51 0.4×	207 1.7×	83	1.3k

Countries citing papers authored by Nicholas Marston

Since Specialization

Citations

This map shows the geographic impact of Nicholas Marston's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicholas Marston with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicholas Marston more than expected).

Fields of papers citing papers by Nicholas Marston

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicholas Marston. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicholas Marston. The network helps show where Nicholas Marston may publish in the future.

Co-authorship network of co-authors of Nicholas Marston

This figure shows the co-authorship network connecting the top 25 collaborators of Nicholas Marston. A scholar is included among the top collaborators of Nicholas Marston based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicholas Marston. Nicholas Marston is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zimerman, André, Frederick Kamanu, Giorgio Melloni, et al.. (2025). Polygenic risk score for coronary artery disease across the spectrum of atherosclerotic disease. European Journal of Preventive Cardiology.

Sampson, Maureen, Anna Wolska, Jeffrey W. Meeusen, et al.. (2025). A Modified Sampson–NIH Equation with Improved Accuracy for Estimating Low Levels of Low-Density Lipoprotein-Cholesterol. Clinical Chemistry. 71(11). 1125–1137. 2 indexed citations

Marston, Nicholas, Brian A. Bergmark, Veronica J. Alexander, et al.. (2025). Design and rationale of the CORE-TIMI 72a and CORE2-TIMI 72b trials of olezarsen in patients with severe hypertriglyceridemia. American Heart Journal. 286. 125–135. 4 indexed citations

Bergmark, Brian A., Nicholas Marston, Thomas A Prohaska, et al.. (2025). Olezarsen in patients with hypertriglyceridemia at high cardiovascular risk: Rationale and design of the Essence–TIMI 73b trial. American Heart Journal. 286. 116–124. 3 indexed citations

Marston, Nicholas, James P. Pirruccello, Giorgio Melloni, et al.. (2024). Clonal hematopoiesis, cardiovascular events and treatment benefit in 63,700 individuals from five TIMI randomized trials. Nature Medicine. 30(9). 2641–2647. 17 indexed citations

Soffer, Daniel, Nicholas Marston, Kevin C. Maki, et al.. (2024). Role of apolipoprotein B in the clinical management of cardiovascular risk in adults: An Expert Clinical Consensus from the National Lipid Association. Journal of clinical lipidology. 18(5). e647–e663. 30 indexed citations

Zimerman, André, Stephen D. Wiviott, Jeong‐Gun Park, et al.. (2024). Reductions in remnant cholesterol and VLDL cholesterol through inhibition of ANGPTL3 protein synthesis: an analysis from the TRANSLATE-TIMI 70 trial. European Journal of Preventive Cardiology. 31(10). 1216–1223. 8 indexed citations

Reza, Nosheen, Raye Lynn Alford, John W. Belmont, & Nicholas Marston. (2024). The Expansion of Genetic Testing in Cardiovascular Medicine: Preparing the Cardiology Community for the Changing Landscape. Current Cardiology Reports. 26(3). 135–146. 6 indexed citations

Bohula, Erin A., Nicholas Marston, Andrea Ruzza, et al.. (2023). Rationale and design of the effect of evolocumab in patients at high cardiovascular risk without prior myocardial infarction or stroke (VESALIUS-CV) trial. American Heart Journal. 269. 179–190. 11 indexed citations

10.

Zimerman, André, Stephen D. Wiviott, Jeong‐Gun Park, et al.. (2023). Hepatic fat changes with antisense oligonucleotide therapy targeting ANGPTL3. Journal of clinical lipidology. 18(2). e261–e268. 6 indexed citations

11.

Marston, Nicholas, Amanda C. Garfinkel, Frederick Kamanu, et al.. (2022). A polygenic risk score predicts atrial fibrillation in cardiovascular disease. European Heart Journal. 44(3). 221–231. 43 indexed citations

12.

Paruchuri, Kaavya, Phoebe Finneran, Nicholas Marston, et al.. (2021). Outcomes of a smartphone-based application with live health-coaching post-percutaneous coronary intervention. EBioMedicine. 72. 103593–103593. 19 indexed citations

13.

Marston, Nicholas, Yared Gurmu, Giorgio Melloni, et al.. (2020). The Effect of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibition on the Risk of Venous Thromboembolism. Circulation. 141(20). 1600–1607. 65 indexed citations

14.

Gencer, Bariş, Nicholas Marston, Christopher P. Cannon, et al.. (2020). Efficacy and safety of lowering LDL cholesterol in older patients: a systematic review and meta-analysis of randomised controlled trials. The Lancet. 396(10263). 1637–1643. 169 indexed citations

15.

Marston, Nicholas, et al.. (2017). Abstract 14894: A Shocking Deficiency: An Unusual Case of Rapidly Progressive Pulmonary Hypertension. Circulation. 1 indexed citations

16.

Marston, Nicholas, William R. Auger, Michael M. Madani, et al.. (2014). ASSESSMENT OF LEFT ATRIAL VOLUME BEFORE AND AFTER PULMONARY THROMBOENDARTERECTOMY IN PATIENTS WITH CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION (CTEPH). Journal of the American College of Cardiology. 63(12). A1485–A1485.

17.

Marston, Nicholas, William R. Auger, Michael M. Madani, et al.. (2014). Assessment of left atrial volume before and after pulmonary thromboendarterectomy in chronic thromboembolic pulmonary hypertension. Cardiovascular Ultrasound. 12(1). 32–32. 11 indexed citations

18.

García, Santiago, Nicholas Marston, Yader Sandoval, et al.. (2012). Prognostic value of 12-lead electrocardiogram and peak troponin I level after vascular surgery. Journal of Vascular Surgery. 57(1). 166–172. 27 indexed citations

19.

Marston, Nicholas, Jorge Brenes, Santiago García, et al.. (2011). Peak postoperative troponin levels outperform preoperative cardiac risk indices as predictors of long-term mortality after vascular surgery. Journal of Critical Care. 27(1). 66–72. 21 indexed citations

20.

Marston, Nicholas. (1995). Beethoven’s Piano Sonata in E, Op. 109. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact